Indi Molecular, Inc. — Form D

Indi Molecular, Inc. of CULVER CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-20. $4.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2017-06-20
• Form: D
• Accession: 0001709279-17-000001
• Industry: Biotechnology
• Exemptions: 06b
• Amount sold: $4.5M
• Investors: 6
• Date of first sale: 2017-06-06
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-289067

Issuer

• Name: Indi Molecular, Inc.
• CIK: 0001709279
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2013
• Address: 6162 BRISTOL PARKWAY, CULVER CITY, CA, 90230
• Phone: 206 576 6340

Officers, directors & promoters (8)

More

• CIK 1709279 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search